Cullinan Therapeutics, Inc. (CGEM) stock
CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$9.50−0.78 (-7.59%)
Close on Nov 16, 2026Market cap $611.37MP/E –Yield –
Cullinan Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Cullinan Therapeutics's pe ratio was 8.5× on Jul 31, 2023.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jul 31, 2023 | 8.5× | +3.7 |
| 2022 | Dec 30, 2022 | 4.8× | – |
See a number that looks wrong?